Kathy Thomas
Gerontology · Tupelo, MSNPI 1396159026
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations.
Across 89 payments — averaging $21.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$349
- Bayer$253
- AstraZeneca$222
- Vifor Pharma, Inc.$180
- Fresenius USA Marketing, Inc.$176
- Akebia Therapeutics Inc$154
- plus $560 from 12 others
What the payments were for
- Food & beverage$1,79495%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 15 | $349 |
| Bayer | 11 | $253 |
| AstraZeneca | 11 | $222 |
| Vifor Pharma, Inc. | 7 | $180 |
| Fresenius USA Marketing, Inc. | 10 | $176 |
| Akebia Therapeutics Inc | 8 | $154 |
| GSK | 5 | $107 |
| Amgen | 4 | $84 |
| Daiichi Sankyo Inc. | 3 | $63 |
| OPKO Pharmaceuticals, LLC | 3 | $56 |
| Travere Therapeutics, Inc. | 3 | $53 |
| Ardelyx, Inc. | 2 | $48 |
| Aurinia Pharma U.S., Inc. | 2 | $41 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Renalytix AI, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $16 |
How this compares
$1,894 in reported general payments places this provider in the 65th percentile of 66 gerontology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VelphoroSucroferric Oxyhydroxide | 94 | $244,616 |
| AuryxiaFerric Citrate | 66 | $107,072 |
| Sevelamer Carbonate | 140 | $30,149 |
| LokelmaSodium Zirconium Cyclosilicate | 15 | $14,814 |
| RayaldeeCalcifediol | 11 | $13,062 |
| Calcium Acetate | 20 | $724 |
| Midodrine Hcl | 17 | $420 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 27 | $370 |
| Ondansetron Hcl | 16 | $334 |
| Nifedipine ErNifedipine | 21 | $331 |
| Omeprazole | 11 | $298 |
| Carvedilol | 46 | $242 |
| Allopurinol | 23 | $228 |
| Pantoprazole Sodium | 30 | $168 |
| Amlodipine Besylate | 29 | $159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Fresenius USA Marketing, Inc.Velphoro | $176 | $244,61694 claims |
| Akebia Therapeutics IncAuryxia | $154 | $107,07266 claims |
| AstraZenecaLokelma | $222 | $14,81415 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $56 | $13,06211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 66 gerontology providers in Mississippi.
Other gerontology in Tupelo
- Meghan MillsTupelo$10K
- Nicole TaylorTupelo$2K
- Hollie WaldronTupelo$2K
- Lakesha ButlerTupelo$817
- Salley WilliamsTupelo$384
- Kellie ThorntonTupelo$280
- Leigh van DevenderOxford$16K
- Justin ColeLaurel$14K
- Shannon WoodsSouthaven$14K
- Shavonne DoyleOxford$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.